Viveve Medical Inc. (VIVE)

[ProfessorCUNY]

Schedule 14A-Information, Point 4, filed a few days ago with the SEC. Viveve called it a Pre-Schedule 14A.

The exact ratio of the reverse split, up to 1 for 10, is to be determined by the Board of Trustees and announced at the annual meeting in July.

The company also will create millions of more shares for their company options and incentive plans. In other words, they will dilute the share base for their own gain and then reduce it on the backs of investors. BAD MEDICINE!

However, if they (with all their incentives) can market this product around the virginal world, we will be able to materially benefit.

Sentiment: Hold, but buy it up if it maintains support level after the reverse split.